Unknown

Dataset Information

0

Megalin-Mediated Tubuloglomerular Alterations in High-Fat Diet-Induced Kidney Disease.


ABSTRACT: Obesity, an important risk factor for metabolic syndrome (MetS) and cardiovascular disease, is often complicated by CKD, which further increases cardiovascular risk and causes ESRD. To elucidate the mechanism underlying this relationship, we investigated the role of the endocytic receptor megalin in proximal tubule epithelial cells (PTECs). We studied a high-fat diet (HFD)-induced obesity/MetS model using kidney-specific mosaic megalin knockout (KO) mice. Compared with control littermates fed a normal-fat diet, control littermates fed an HFD for 12 weeks showed autolysosomal dysfunction with autophagy impairment and increased expression of hypertrophy, lipid peroxidation, and senescence markers in PTECs of the S2 segment, peritubular capillary rarefaction with localized interstitial fibrosis, and glomerular hypertrophy with mesangial expansion. These were ameliorated in HFD-fed megalin KO mice, even though these mice had the same levels of obesity, dyslipidemia, and hyperglycemia as HFD-fed control mice. Intravital renal imaging of HFD-fed wild-type mice also demonstrated the accumulation of autofluorescent lipofuscin-like substances in PTECs of the S2 segment, accompanied by focal narrowing of tubular lumens and peritubular capillaries. In cultured PTECs, fatty acid-rich albumin induced the increased expression of genes encoding PDGF-B and monocyte chemoattractant protein-1 via megalin, with large (auto)lysosome formation, compared with fatty acid-depleted albumin. Collectively, the megalin-mediated endocytic handling of glomerular-filtered (lipo)toxic substances appears to be involved primarily in hypertrophic and senescent PTEC injury with autophagy impairment, causing peritubular capillary damage and retrograde glomerular alterations in HFD-induced kidney disease. Megalin could be a therapeutic target for obesity/MetS-related CKD, independently of weight, dyslipidemia, and hyperglycemia modification.

SUBMITTER: Kuwahara S 

PROVIDER: S-EPMC4926965 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3187184 | biostudies-literature
| S-EPMC7173843 | biostudies-literature
| S-EPMC8295594 | biostudies-literature
| S-EPMC9039870 | biostudies-literature
| S-EPMC10215342 | biostudies-literature
| S-EPMC10934936 | biostudies-literature
| S-EPMC7718043 | biostudies-literature
| S-EPMC7934847 | biostudies-literature
| S-EPMC9368634 | biostudies-literature
| S-EPMC7507204 | biostudies-literature